Table 1

Study characteristics by condition

Main publication
(associated papers)
Country
Study design
N in study (n in analyses)
Population
% male
Mean age (SD)
Intervention (I)
Comparator (C)
CointerventionsLength of follow-up
Postpolio syndrome
Bocker et al 15 (Bocker et al 36)
Germany
Case series
n=10 (6)
30
64.5
I: carbon fibre KAFO
C: no comparator
Gait training, pain therapy and exercises
(twice per week for 3 months)
3 months
Brehm et al 11
Netherlands
Case series
n=23 (20)
61
55 (9.2)
I: carbon fibre KAFO (locked knee-joint)
C: leather/metal or plastic/metal KAFO used previously by same participants
Walking aids were used by some participants26 weeks
Davis et al 14
Australia
Case series
n=10 (10)
40
61.9 (7.7)
I: carbon fibre SCKAFO in stance control mode
C: KAFO in locked knee mode used by same participants
Walking aidsMean duration of use at time of evaluation 6.2 (SD 5.2) months
Hachisuka et al 12
Japan
(Hachisuka et al 37)
Case series
n=11 (8–11*)
18
53.9 (9.8)
I: carbon fibre KAFO
C: traditional non-carbon KAFO used by same participants
Walking aidsNot reported
Heim et al 17
Israel
Case series
n=30 (27)
33
44
I: carbon fibre KAFO
C: no comparator
Not reported30 months
Peethambaran et al 13
USA
Case series
n=5 (5)
40
61.4 (12.4)
I: carbon titanium KAFO (anterior approach design)
C: plastic KAFO (posterior approach design) used previously by the same participants
Not reported6 weeks
Steinfeldt et al 16
Germany
Case series
n=55 (55)
44
58
I: carbon fibre KAFO
C: no comparator
Not reported>3 months
Inclusion body myositis
Bernhardt et al 18
USA
Case series
n=9 (6)
78
61 (9)
I: SCKAFO
C: no comparator
Not reported6 months
Poststroke
Boudarham et al 21
France
Case series
n=11 (unclear)
64
51 (15)
I: carbon fibre KAFO
C: no comparator
Not reportedDevice prescribed within past 6 months
Kakurai and Akai10
Japan
Case series
n=28 (28)
50
54.5
I: plastic convertible KAFO (to AFO)
C: participants who changed to AFO compared with those remaining on KAFO
Not reportedNot reported
Morinaka et al 20
Japan
Cohort study
n=25 (25)
64
56
I: plastic KAFO
C: 50 participants fitted with AFOs and a group of 30 healthy adult males
Not reportedMean 14.6 months (range 1–35)
Yang et al 19
China
RCT
n=67 (67)
84
58
I: KAFO or AFO
C: ‘Conventional rehabilitation’
Not reportedNot reported
Spinal cord injury
Harvey et al 22
(Harvey et al,38 Harvey et al 39)
Australia
RCT
(crossover)
n=10 (5–10†)
90
37 (8.4)
I: HKAFO (Walkabout orthosis)
C: HKAFO (IRGO)
Gait training (30–54 hours per orthosis)
Crutches
28 weeks
Jaspers et al 25
Belgium
Case series
n=14 (14)
86
33.6
I: HKAFO (ARGO)
C: no comparator
Walker or crutches1 year
Middleton et al 26
Australia
Case series
n=25 (21)
76
35 (13)
I: HKAFO (Walkabout orthosis)
C: no comparator
Parallel bars, forearm crutches or frames≥18 months
Scivoletto et al 27
Italy
Case series
n=24 (24‡)
79
33.6 (3.2)
I: HKAFO (RGO)
C: no comparator (internal comparison of non-users vs users)
Not reported1 year
Summers et al 28
UK
Case series
n=20 (20)
100
28
I: HKAFO (HGO ParaWalker)
C: no comparator
Crutches used as decided by patientMean 20 months
Sun et al 29
China
Case series
n=20 (15)
67
33.7
I: HKAFO (RGO)
C: no comparator
Not reportedNot reported
Tang et al 23
China
Controlled study
n=58 (unclear)
83
32.4
I: AGO, RGO, KAFO
C: rehabilitation training
Rehabilitation training4 months§
Whittle et al 24
UK
Controlled study (crossover)
n=22 (Unclear¶)
82
34
I: HKAFO (HGO ParaWalker)
C: HKAFO (RGO)
Rollator or crutches4 months
Wu et al 30
China
Case series
n=6 (6)
67
27.6
I: HKAFO (Walkabout orthosis)
C: no comparator group
Gait training including balance plus walking exercisesUnclear
  • *Eight completed assessment of non-carbon fibre KAFO and walking without an orthosis and 11 completed assessment of carbon fibre KAFO.

  • †Appears to be 22 for analysis of final choice of orthosis, although one left the trial without trying either and three participants tried only one. It was unclear how many participants were included in other analyses.

  • ‡Appears to be 10 for all analyses except for speed of walking on flat surface (n=8) and speed of walking on ramp (n=5).

  • §Eight weeks after fitting of device.

  • ¶A total of 24 for the single outcome eligible for the review, although unclear for other analyses in the study.

  • AFO, ankle-foot orthosis; AGO, alternative gait orthosis; ARGO, advanced reciprocating gait orthosis; HGO, hip guidance orthosis; IRGO, isocentric reciprocating gait orthosis; KAFO, knee-ankle-foot orthosis; RGO, reciprocating gait orthosis; SCKAFO, stance-control knee-ankle-foot orthosis.